Sensitive allele-specific PCR assay able to detect FGFR3 mutations in tumors and urine from patients with urothelial cell carcinoma of the bladder

被引：9

作者：

Bakkar, AA

Quach, V

Le Borgne, A

Toublanc, M

Henin, D

Wallerand, H

Radvanyi, F

Bittard, H

Ravery, V

Gibod, LB

de Medina, SGD

Chopin, DK

Grandchamp, B

机构：

[1] Univ Paris 12, Hop Henri Mondor, EMI 03 37, INSERM, F-94010 Creteil, France

[2] Univ Paris 12, Hop Henri Mondor, AP HP, Serv Urol, F-94010 Creteil, France

[3] Univ Paris 07, AP HP, IFR02, Hop Bichat Claude Bernard,Serv Biochim & Genet, Paris, France

[4] Univ Paris 07, AP HP, IFR02, Hop Bichat Claude Bernard,Serv Anat & Cytol Patho, Paris, France

[5] Univ Paris 07, AP HP, IFR02, Hop Bichat Claude Bernard,Serv Urol, Paris, France

[6] Inst Curie, CNRS, UMR 144, F-75231 Paris, France

[7] CHRU Besancon, Serv Urol, Besancon, France

来源：

CLINICAL CHEMISTRY | 2005年 / 51卷 / 08期

关键词：

D O I：

10.1373/clinchem.2005.049619

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：1555 / 1557

页数：3

共 10 条

[1] Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors [J].

Billerey, C ;

Chopin, D ;

Aubriot-Lorton, MH ;

Ricol, D ;

de Medina, SGD ;

Van Rhijn, B ;

Bralet, MP ;

Lefrere-Belda, MA ;

Lahaye, JB ;

Abbou, CC ;

Bonaventure, J ;

Zafrani, ES ;

van der Kwast, T ;

Thiery, JP ;

Radvanyi, F .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) :1955-1959

[2] PCR AMPLIFICATION OF SPECIFIC ALLELES - RAPID DETECTION OF KNOWN MUTATIONS AND POLYMORPHISMS [J].

BOTTEMA, CDK ;

SOMMER, SS .

MUTATION RESEARCH, 1993, 288 (01) :93-102

[3] Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas [J].

Cappellen, D ;

De Oliveira, C ;

Ricol, D ;

de Medina, SGD ;

Bourdin, J ;

Sastre-Garau, X ;

Chopin, D ;

Thiery, JP ;

Radvanyi, F .

NATURE GENETICS, 1999, 23 (01) :18-20

[4] Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder [J].

Cappellen, D ;

deMedina, SGD ;

Chopin, D ;

Thiery, JP ;

Radvanyi, F .

ONCOGENE, 1997, 14 (25) :3059-3066

[5]

MOSTOFI F, 1973, INT HISTOLIGICAL CLA

[6] Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection [J].

Rieger-Christ, KM ;

Mourtzinos, A ;

Lee, PJ ;

Zagha, RM ;

Cain, J ;

Silverman, M ;

Libertino, JA ;

Summerhayes, IC .

CANCER, 2003, 98 (04) :737-744

[7]

SOBIN LH, 1997, TNM CLASSIFICATION M, V80, P1803

[8]

van Rhijn BWG, 2003, CLIN CANCER RES, V9, P257

[9] Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders [J].

van Rhijn, BWG ;

van Tilborg, AAG ;

Lurkin, I ;

Bonaventure, J ;

de Vries, A ;

Thiery, JP ;

van der Kwast, TH ;

Zwarthoff, EC ;

Radvanyi, F .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (12) :819-824

[10] Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? [J].

Wiener, HG ;

Mian, C ;

Haitel, A ;

Pycha, A ;

Schatzl, G ;

Marberger, M .

JOURNAL OF UROLOGY, 1998, 159 (06) :1876-1880

← 1 →